Pharmacodynamics of polymyxin B against Pseudomonas aeruginosa

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 9, 2005, Pages 3624-3630

  Tam, Vincent H ^a   Schilling, Amy N ^a   Vo, Giao ^a   Kabbara, Samer ^a   Kwa, Andrea L ^b   Wiederhold, Nathan P ^a,c   Lewis, Russell E ^a  

^a UNIVERSITY OF HOUSTON   (United States)

^b SINGAPORE GENERAL HOSPITAL   (Singapore)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZTREONAM; CEFTAZIDIME; COLISTIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; PIPERACILLIN; POLYMYXIN B; TOBRAMYCIN;

ARTICLE; BACTERIAL INFECTION; BACTERIAL STRAIN; COLONY FORMING UNIT; CONCENTRATION RESPONSE; DOSE TIME EFFECT RELATION; GRAM NEGATIVE BACTERIUM; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR CLONING; MULTIDRUG RESISTANCE; NONHUMAN; PHARMACODYNAMICS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STEADY STATE; WILD TYPE;

ANTI-BACTERIAL AGENTS; COLONY COUNT, MICROBIAL; DRUG RESISTANCE, BACTERIAL; KINETICS; MICROBIAL SENSITIVITY TESTS; MODELS, BIOLOGICAL; POLYMYXIN B; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 24144457739     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.9.3624-3630.2005     Document Type: Article

References (23)

1. Bilello, J. A., G. Bauer, M. N. Dudley, G. A. Cole, and G. L. Drusano. 1994. Effect of 2′,3′-didehydro-3′-deoxythymidine in an in vitro hollow-fiber pharmacodynamic model system correlates with results of dose-ranging clinical studies. Antimicrob. Agents Chemother. 38:1386-1391.
2. Cooperstock, M. S. 1974. Inactivation of endotoxin by polymyxin B. Antimicrob. Agents Chemother. 6:422-425.
3. D'Argenio, D. Z., and A. Schumitzky. 1997. ADAPT 11 user's guide pharmacokinetic/pharmacodynamic systems analysis software. Biomedical simulations resource, University of Southern California, Los Angeles.
4. Drusano, G. L. 2004. Antimicrobial pharmacodynamics critical interactions of 'bug and drug'. Nat. Rev. Microbiol. 2:289-300.
5. Evans, M. E., D. J. Feola, and R. P. Rapp. 1999. Polymyxin B sulfate and colistin old antibiotics for emerging multiresistant gram-negative bacteria. Ann. Pharmacother. 33:960-967.
6. Garnacho-Montero, J., C. Ortiz-Leyba, F. J. Jimenez-Jimenez, A. E. Barrero-Almodovar, J. L. Garcia-Garmendia, I. M. Bernabeu-Wittel, S. L. Gallego-Lara, and J. Madrazo-Osuna. 2003. Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin a comparison with imipenem-susceptible VAP. Clin. Infect. Dis. 36:1111-1118.
7. Gilleland, H. E., Jr., and R. D. Lyle. 1979. Chemical alterations in cell envelopes of polymyxin-resistant Pseudomonas aeruginosa isolates. J. Bacteriol. 138:839-845.
8. Gunderson, B. W., K. H. Ibrahim, L. B. Hovde, T. L. Fromm, M. D. Reed, and J. C. Rotschafer. 2003. Synergistic activity of colistin and ceftazidime against multiantibiotic-resistant Pseudomonas aeruginosa in an in vitro pharmacodynamic model. Antimicrob. Agents Chemother. 47:905-909.
9. Hamer, D. H. 2000. Treatment of nosocomial pneumonia and tracheobronchitis caused by multidrug-resistant Pseudomonas aeruginosa with aerosolized colistin. Am. J. Respir. Crit. Care Med. 162:328-330.
10. Hermsen, E. D., C. J. Sullivan, and J. C. Rotschafer. 2003. Polymyxins pharmacology, pharmacokinetics, pharmacodynamics, and clinical applications. Infect. Dis. Clin. N. Am. 17:545-562.
11. Levin, A. S., A. A. Barone, J. Pence, M. V. Santos, I. S. Marinho, E. A. Arruda, E. I. Manrique, and S. F. Costa. 1999. Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii. Clin. Infect. Dis. 28:1008-1011.
12. Li, J., J. Turnidge, R. Milne, R. L. Nation, and K. Coulthard. 2001. In vitro pharmacodynamic properties of colistin and colistin methanesulfonate against Pseudomonas aeruginosa isolates from patients with cystic fibrosis. Antimicrob. Agents Chemother. 45:781-785.
13. Linden, P. K., S. Kusne, K. Coley, P. Fontes, D. J. Kramer, and D. Paterson. 2003. Use of parenteral colistin for the treatment of serious infection due to antimicrobial-resistant Pseudomonas aeruginosa. Clin. Infect. Dis. 37:e154-e160.
14. Mahenthiralingam, E., M. E. Campbell, J. Foster, J. S. Lam, and D. P. Speert. 1996. Random amplified polymorphic DNA typing of Pseudomonas aeruginosa isolates recovered from patients with cystic fibrosis. J. Clin. Microbiol. 34:1129-1135.
15. Markou, N., H. Apostolakos, C. Koumoudiou, M. Athanasiou, A. Koutsoukou, I. Alamanos, and L. Gregorakos. 2003. Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients. Crit. Care 7:R78-R83.
16. Michalopoulos, A. S., S. Tsiodras, K. Helios, S. Mentzelopoulos, and M. E. Falagas. 2005. Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria the renaissance of an old antibiotic. Clin. Microbiol. Infect. 11:115-121.
17. Morrison, D. C., and D. M. Jacobs. 1976. Inhibition of lipopolysaccharide-initiated activation of serum complement by polymyxin B. Infect. Immun. 13:298-301.
18. NCCLS. 2003. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerohically; approved standard, 6th ed. NCCLS, Wayne, Pa.
19. Nicas, T. I., and R. E. Hancock. 1980. Outer membrane protein H1 of Pseudomonas aeruginosa involvement in adaptive and mutational resistance to ethylenediaminetetraacetate, polymyxin B, and gentamicin. J. Bacteriol. 143:872-878.
20. Obritsch, M. D., D. N. Fish, R. MacLaren, and R. Jung. 2004. National surveillance of antimicrobial resistance in Pseudomonas aeruginosa isolates obtained from intensive care unit patients from 1993 to 2002. Antimicrob. Agents Chemother. 48:4606-4610.
21. Ouderkirk, J. P., J. A. Nord, G. S. Turett, and J. W. Kislak. 2003. Polymyxin B nephrotoxicity and efficacy against nosocomial infections caused by multiresistant gram-negative bacteria. Antimicrob. Agents Chemother. 47:2659-2662.
22. Shand, G. H., H. Anwar, and M. R. Brown. 1988. Outer membrane proteins of polymyxin resistant Pseudomonas aeruginosa effect of magnesium depletion. J. Antimicrob. Chemother. 22:811-821.
23. Sobieszczyk, M. E., E. Y. Furuya, C. M. Hay, P. Pancholi, P. Della-Latta, S. M. Hammer, and C. J. Kubin. 2004. Combination therapy with polymyxin B for the treatment of multidrug-resistant Gram-negative respiratory tract infections. J. Antimicrob. Chemother. 54:566-569.